The DOI matches its Crossref record; 80 of the 80 references it cites were found in a registry or an index.
Drug resistance and treatment failure in leishmaniasis: A 21st century challenge
Open accessAbstract
Reevaluation of treatment guidelines for Old and New World leishmaniasis is urgently needed on a global basis because treatment failure is an increasing problem. Drug resistance is a fundamental determinant of treatment failure, although other factors also contribute to this phenomenon, including the global HIV/AIDS epidemic with its accompanying impact on the immune system. Pentavalent antimonials have been used successfully worldwide for the treatment of leishmaniasis since the first half of the 20th century, but the last 10 to 20 years have witnessed an increase in clinical resistance, e.g., in North Bihar in India. In this review, we discuss the meaning of "resistance" related to leishmaniasis and discuss its molecular epidemiology, particularly for Leishmania donovani that causes visceral leishmaniasis. We also discuss how resistance can affect drug combination therapies. Molecular mechanisms known to contribute to resistance to antimonials, amphotericin B, and miltefosine are also outlined.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Drug Resistance in Leishmaniasis
Croft, S. L., Sundar, S., & Fairlamb, A. H. (2006) · Clinical Microbiology Reviews · doi:10.1128/cmr.19.1.111-126.2006 · Cited by 1,663
Amphotericin B: 30 Years of Clinical Experience
Gallis, H. A., Drew, R. H., & Pickard, W. W. (1990) · Clinical Infectious Diseases · doi:10.1093/clinids/12.2.308 · Cited by 1,009
The Relationship between Leishmaniasis and AIDS: the Second 10 Years
Alvar, J., Aparicio, P., Aseffa, A., Den Boer, M., Cañavate, C., Dedet, J.-P., Gradoni, L., Ter Horst, R., López-Vélez, R., & Moreno, J. (2008) · Clinical Microbiology Reviews · doi:10.1128/cmr.00061-07 · Cited by 937
Oral Miltefosine for Indian Visceral Leishmaniasis
Sundar, S., Jha, T. K., Thakur, C. P., Engel, J., Sindermann, H., Fischer, C., Junge, K., Bryceson, A., & Berman, J. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa021556 · Cited by 779
Miltefosine: a review of its pharmacology and therapeutic efficacy in the treatment of leishmaniasis
Dorlo, T. P. C., Balasegaram, M., Beijnen, J. H., & de Vries, P. J. (2012) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dks275 · Cited by 775
Amphotericin primarily kills yeast by simply binding ergosterol
Gray, K. C., Palacios, D. S., Dailey, I., Endo, M. M., Uno, B. E., Wilcock, B. C., & Burke, M. D. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1117280109 · Cited by 608
Amphotericin forms an extramembranous and fungicidal sterol sponge
Anderson, T. M., Clay, M. C., Cioffi, A. G., Diaz, K. A., Hisao, G. S., Tuttle, M. D., Nieuwkoop, A. J., Comellas, G., Maryum, N., Wang, S., et al. (2014) · Nature Chemical Biology · doi:10.1038/nchembio.1496 · Cited by 528
Single-Dose Liposomal Amphotericin B for Visceral Leishmaniasis in India
Sundar, S., Chakravarty, J., Agarwal, D., Rai, M., & Murray, H. W. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0903627 · Cited by 434
Leishmaniasis chemotherapy—challenges and opportunities
Croft, S. L., & Olliaro, P. (2011) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2011.03630.x · Cited by 424
Miltefosine for New World Cutaneous Leishmaniasis
Soto, J., Arana, B. A., Toledo, J., Rizzo, N., Vega, J. C., Diaz, A., Luz, M., Gutierrez, P., Arboleda, M., Berman, J. D., et al. (2004) · Clinical Infectious Diseases · doi:10.1086/383321 · Cited by 385
Leishmaniasis in immunosuppressed individuals
van Griensven, J., Carrillo, E., López-Vélez, R., Lynen, L., & Moreno, J. (2014) · Clinical Microbiology and Infection · doi:10.1111/1469-0691.12556 · Cited by 348
Self-citationSundar, S., Sinha, P. K., Rai, M., Verma, D. K., Nawin, K., Alam, S., Chakravarty, J., Vaillant, M., Verma, N., Pandey, K., et al. (2011) · The Lancet · doi:10.1016/s0140-6736(10)62050-8 · Cited by 337
Mechanism of Amphotericin B Resistance in Clinical Isolates of Leishmania donovani
Purkait, B., Kumar, A., Nandi, N., Sardar, A. H., Das, S., Kumar, S., Pandey, K., Ravidas, V., Kumar, M., De, T., et al. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00030-11 · Cited by 324
Fitness Trade-offs Restrict the Evolution of Resistance to Amphotericin B
Vincent, B. M., Lancaster, A. K., Scherz-Shouval, R., Whitesell, L., & Lindquist, S. (2013) · PLoS Biology · doi:10.1371/journal.pbio.1001692 · Cited by 322
Rijal, S., Ostyn, B., Uranw, S., Rai, K., Bhattarai, N. R., Dorlo, T. P. C., Beijnen, J. H., Vanaerschot, M., Decuypere, S., Dhakal, S. S., et al. (2013) · Clinical Infectious Diseases · doi:10.1093/cid/cit102 · Cited by 319
Self-citationLemke, A., Kiderlen, A. F., & Kayser, O. (2005) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-005-1955-9 · Cited by 305
Impact of poor-quality medicines in the ‘developing’ world
Newton, P. N., Green, M. D., & Fernández, F. M. (2010) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2009.11.005 · Cited by 289
Ouellette, M., Fase-Fowler, F., & Borst, P. (1990) · The EMBO Journal · doi:10.1002/j.1460-2075.1990.tb08206.x · Cited by 259
The Leishmania ATP-binding Cassette Protein PGPA Is an Intracellular Metal-Thiol Transporter ATPase
Légaré, D., Richard, D., Mukhopadhyay, R., Stierhof, Y.-D., Rosen, B. P., Haimeur, A., Papadopoulou, B., & Ouellette, M. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m102351200 · Cited by 242
Self-citationMolecular mechanisms of antimony resistance in Leishmania
Ashutosh, Sundar, S., & Goyal, N. (2007) · Journal of Medical Microbiology · doi:10.1099/jmm.0.46841-0 · Cited by 222
Drug Resistance in Visceral Leishmaniasis
Maltezou, H. C. (2010) · Journal of Biomedicine and Biotechnology · doi:10.1155/2010/617521 · Cited by 218
Dumetz, F., Imamura, H., Sanders, M., Seblova, V., Myskova, J., Pescher, P., Vanaerschot, M., Meehan, C. J., Cuypers, B., De Muylder, G., et al. (2017) · mBio · doi:10.1128/mbio.00599-17 · Cited by 193
Self-citationDisruption of Ergosterol Biosynthesis Confers Resistance to Amphotericin B in Candida lusitaniae
Young, L. Y., Hull, C. M., & Heitman, J. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.9.2717-2724.2003 · Cited by 186
Leprohon, P., Legare, D., Raymond, F., Madore, E., Hardiman, G., Corbeil, J., & Ouellette, M. (2009) · Nucleic Acids Research · doi:10.1093/nar/gkn1069 · Cited by 183
Ubeda, J.-M., Légaré, D., Raymond, F., Ouameur, A. A., Boisvert, S., Rigault, P., Corbeil, J., Tremblay, M. J., Olivier, M., Papadopoulou, B., et al. (2008) · Genome Biology · doi:10.1186/gb-2008-9-7-r115 · Cited by 175
Self-citationEvolutionary genomics of epidemic visceral leishmaniasis in the Indian subcontinent
Imamura, H., Downing, T., Van den Broeck, F., Sanders, M. J., Rijal, S., Sundar, S., Mannaert, A., Vanaerschot, M., Berg, M., De Muylder, G., et al. (2016) · eLife · doi:10.7554/elife.12613 · Cited by 173
Self-citationAdaptive mechanisms in pathogens: universal aneuploidy in Leishmania
Mannaert, A., Downing, T., Imamura, H., & Dujardin, J. (2012) · Trends in Parasitology · doi:10.1016/j.pt.2012.06.003 · Cited by 167
Self-citationLeishmania RNA virus: when the host pays the toll
Hartley, M., Ronet, C., Zangger, H., Beverley, S. M., & Fasel, N. J. (2012) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2012.00099 · Cited by 162
Laboratory confirmed miltefosine resistant cases of visceral leishmaniasis from India
Srivastava, S., Mishra, J., Gupta, A. K., Singh, A., Shankar, P., & Singh, S. (2017) · Parasites & Vectors · doi:10.1186/s13071-017-1969-z · Cited by 154
Fadili, K. E., Messier, N., Leprohon, P., Roy, G., Guimond, C., Trudel, N., Saravia, N. G., Papadopoulou, B., Légaré, D., & Ouellette, M. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.5.1988-1993.2005 · Cited by 149
Self-citationRamos, H., Valdivieso, E., Gamargo, M., Dagger, F., & Cohen, B. E. (1996) · The Journal of Membrane Biology · doi:10.1007/s002329900086 · Cited by 142
Ubeda, J.-M., Raymond, F., Mukherjee, A., Plourde, M., Gingras, H., Roy, G., Lapointe, A., Leprohon, P., Papadopoulou, B., Corbeil, J., et al. (2014) · PLoS Biology · doi:10.1371/journal.pbio.1001868 · Cited by 142
Self-citationPérez-Victoria, J. M., Pérez‐Victoria, F. J., Parodi‐Talice, A., Jiménez, I. A., Ravelo, Á. G., Castanys, S., & Gamarro, F. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.9.2468-2474.2001 · Cited by 140
Self-citationPlasticity of the Leishmania genome leading to gene copy number variations and drug resistance
Laffitte, M.-C. N., Leprohon, P., Papadopoulou, B., & Ouellette, M. (2016) · F1000Research · doi:10.12688/f1000research.9218.1 · Cited by 140
Self-citationExploiting Knowledge on Leishmania Drug Resistance to Support the Quest for New Drugs
Hefnawy, A., Berg, M., Dujardin, J., & Muylder, G. D. (2016) · Trends in Parasitology · doi:10.1016/j.pt.2016.11.003 · Cited by 140
Self-citationBourreau, E., Ginouvès, M., Prévot, G., et al. (2015) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiv355 · Cited by 136
Adaui, V., Lye, L., Akopyants, N. S., Zimic, M., Llanos‐Cuentas, A., García, L., Maes, I., Doncker, S. D., Dobson, D. E., Arévalo, J., et al. (2015) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiv354 · Cited by 135
Self-citationRakotomanga, M., Saint-Pierre-Chazalet, M., & Loiseau, P. M. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.7.2677-2686.2005 · Cited by 133
Forastiero, A., Mesa-Arango, A. C., Alastruey-Izquierdo, A., Alcazar-Fuoli, L., Bernal-Martinez, L., Pelaez, T., Lopez, J. F., Grimalt, J. O., Gomez-Lopez, A., Cuesta, I., et al. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00477-13 · Cited by 131
Visceral Leishmaniasis and HIV Coinfection in Latin America
Lindoso, J. Â. L., Cota, G., da Cruz, A. M., Goto, H., Maia‐Elkhoury, A. N. S., Romero, G. A. S., de Sousa-Gomes, M. L., Santos-Oliveira, J. R., & Rabello, A. (2014) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0003136 · Cited by 127
CHARACTERIZATION OF NATURAL ANTIMONY RESISTANCE IN LEISHMANIA DONOVANI ISOLATES
Mittal, M. K., Rai, S., Ashutosh, A., et al. (2007) · American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.2007.76.681 · Cited by 126
Gene expression regulation in trypanosomatids
De Gaudenzi, J. G., Noé, G., Campo, V. A., Frasch, A. C., & Cassola, A. (2011) · Essays in Biochemistry · doi:10.1042/bse0510031 · Cited by 116
Leishmania donovani Develops Resistance to Drug Combinations
García‐Hernández, R., Manzano, J. I., Castanys, S., & Gamarro, F. (2012) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0001974 · Cited by 116
Self-citationSokol-Anderson, M., Sligh, J. E., Elberg, S., Brajtburg, J., Kobayashi, G. S., & Medoff, G. (1988) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.32.5.702 · Cited by 113
Optimal Dosing of Miltefosine in Children and Adults with Visceral Leishmaniasis
Dorlo, T. P. C., Huitema, A. D. R., Beijnen, J. H., & de Vries, P. J. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00292-12 · Cited by 111
Mandal, G., Wyllie, S., Singh, N., Sundar, S., Fairlamb, A. H., & Chatterjee, M. (2007) · Parasitology · doi:10.1017/s0031182007003150 · Cited by 110
Coelho, A. C., Boisvert, S., Mukherjee, A., Leprohon, P., Corbeil, J., & Ouellette, M. (2012) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0001512 · Cited by 109
Wasunna, M. K., Njenga, S., Balasegaram, M., Alexander, N. D. E., Omollo, R., Edwards, T., Dorlo, T. P. C., Younis, B. M., Ali, M. H. S., Elamin, M. Y., et al. (2016) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0004880 · Cited by 106
Mukherjee, B., Mukhopadhyay, R., Banerjee, B., Chowdhury, S., Mukherjee, S., Naskar, K., Allam, U. S., Chakravortty, D., Sundar, S., Dujardin, J., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1213839110 · Cited by 102
Self-citationA New ABC Half-Transporter in Leishmania major Is Involved in Resistance to Antimony
Manzano, J. I., García‐Hernández, R., Castanys, S., & Gamarro, F. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00211-13 · Cited by 91
Self-citationQuantitative proteomic analysis of amphotericin B resistance in Leishmania infantum
Brotherton, M., Bourassa, S., Légaré, D., Poirier, G. G., Droit, A., & Ouellette, M. (2014) · International Journal for Parasitology Drugs and Drug Resistance · doi:10.1016/j.ijpddr.2014.05.002 · Cited by 89
Parasexuality and mosaic aneuploidy in Leishmania: alternative genetics
Sterkers, Y., Crobu, L., Lachaud, L., Pagès, M., & Bastien, P. (2014) · Trends in Parasitology · doi:10.1016/j.pt.2014.07.002 · Cited by 88
Pourshafie, M. R., Morand, S. C., Virion, A., Rakotomanga, M., Dupuy, C., & Loiseau, P. M. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.7.2409-2414.2004 · Cited by 85
Fernandez‐Prada, C., Vincent, I. M., Brotherton, M., Roberts, M., Roy, G., Rivas, L., Leprohon, P., Smith, T., & Ouellette, M. (2016) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0005171 · Cited by 81
Treatment of Cutaneous Leishmaniasis Caused by Leishmania aethiopica: A Systematic Review
van Griensven, J., Gadisa, E., Aseffa, A., Hailu, A., Beshah, A. M., & Diro, E. (2016) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0004495 · Cited by 79
Sterol 14α-demethylase mutation leads to amphotericin B resistance in Leishmania mexicana
Mwenechanya, R., Kovářová, J., Dickens, N. J., Mudaliar, M., Herzyk, P., Vincent, I. M., Weidt, S. K., Burgess, K. E., Burchmore, R., Pountain, A. W., et al. (2017) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0005649 · Cited by 79
Self-citationRai, K., Cuypers, B., Bhattarai, N. R., Uranw, S. K., Berg, M., Ostyn, B., Dujardin, J., Rijal, S., & Vanaerschot, M. (2013) · mBio · doi:10.1128/mbio.00611-13 · Cited by 78
Self-citationCellular Transport and Lipid Interactions of Miltefosine
BARRATT, G. M., Saint-Pierre-Chazalet, M., & Loiseau, P. M. (2009) · Current Drug Metabolism · doi:10.2174/138920009787846332 · Cited by 73
Drug resistance mechanisms in clinical isolates of Leishmania donovani.
Singh, N. (2006) · PubMed · Cited by 73
Drug Resistance in Leishmania Parasites: Consequences, Molecular Mechanisms and Possible Treatments
Ponte‐Sucre, A., Díaz, E., & Padrón-Nieves, M. (2012) · Springer eBooks · doi:10.1007/978-3-7091-1125-3 · Cited by 71
Self-citationBhandari, V., Sundar, S., Dujardin, J., & Salotra, P. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01574-13 · Cited by 70
Self-citationMondal, D., Alvar, J., Hasnain, M. G., Hossain, M. S., Ghosh, D., Huda, M. M., Nabi, S. G., Sundar, S., Matlashewski, G., & Arana, B. A. (2013) · The Lancet Global Health · doi:10.1016/s2214-109x(13)70118-9 · Cited by 70
Papadopoulou, B., Roy, G., & Ouellette, M. (1993) · Nucleic Acids Research · doi:10.1093/nar/21.18.4305 · Cited by 69
Self-citationVanaerschot, M., Huijben, S., den Broeck, F. V., & Dujardin, J. (2013) · FEMS Microbiology Reviews · doi:10.1111/1574-6976.12032 · Cited by 60
Self-citationHow to succeed in parasitic life without sex? Asking Leishmania
Victoir, K., & Dujardin, J. (2002) · Trends in Parasitology · doi:10.1016/s1471-4922(01)02199-7 · Cited by 57
Self-citationMartínez-Valencia, A. J., Daza-Rivera, C. F., Rosales-Chilama, M., Cossio, A., Rincón, E. J. C., Desai, M. M., Saravia, N. G., & Gómez, M. A. (2017) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0005713 · Cited by 56
Kulshrestha, A., Sharma, V., Singh, R., & Salotra, P. (2014) · Parasitology Research · doi:10.1007/s00436-014-3755-6 · Cited by 54
Berg, M., García‐Hernández, R., Cuypers, B., Vanaerschot, M., Manzano, J. I., Poveda, J. A., Ferragut, J. A., Castanys, S., Dujardin, J., & Gamarro, F. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.04231-14 · Cited by 53
Self-citationPerry, M. R., Wyllie, S., Prajapati, V. K., Feldmann, J., Sundar, S., Boelaert, M., & Fairlamb, A. H. (2011) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0001227 · Cited by 51
AL-Mohammed, H. I., Chance, M. L., & Bates, P. A. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.8.3274-3280.2005 · Cited by 51
Fitness of Leishmania donovani Parasites Resistant to Drug Combinations
García‐Hernández, R., Gómez‐Pérez, V., Castanys, S., & Gamarro, F. (2015) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0003704 · Cited by 48
Self-citation(Post-) Genomic approaches to tackle drug resistance in Leishmania
Berg, M., Mannaert, A., Vanaerschot, M., der Auwera, G. V., & Dujardin, J. (2013) · Parasitology · doi:10.1017/s0031182013000140 · Cited by 47
Self-citationPerry, M. R., Prajapati, V. K., Menten, J., Raab, A., Feldmann, J., Chakraborti, D., Sundar, S., Fairlamb, A. H., Boelaert, M., & Picado, A. (2015) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0003518 · Cited by 47
Significantly Lower Anti-Leishmania IgG Responses in Sudanese versus Indian Visceral Leishmaniasis
Bhattacharyya, T., Bowes, D. E., EL-Safi, S. H., Sundar, S., Falconar, A. K. I., Singh, O. P., Kumar, R., Ahmed, O., Boelaert, M., & Miles, M. A. (2014) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0002675 · Cited by 39
Kündig, C., Leblanc, E., Papadopoulou, B., & Ouellette, M. (1999) · Nucleic Acids Research · doi:10.1093/nar/27.18.3653 · Cited by 37
Self-citationAndrade-Narvaez, F. J., Loría‐Cervera, E. N., Sosa-Bibiano, E. I., & Wynsberghe, N. R. V. (2016) · Memórias do Instituto Oswaldo Cruz · doi:10.1590/0074-02760160138 · Cited by 37
Rai, K., Bhattarai, N. R., Vanaerschot, M., Imamura, H., Gebru, G., Khanal, B., Rijal, S., Boelaert, M., Pal, C., Karki, P., et al. (2017) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0005420 · Cited by 30
Self-citationSodium Stibogluconate: Therapeutic use in the Management of Leishmaniasis
Roychoudhury, J., & Ali, N. (2008) · Indian Journal of Biochemistry and Biophysics · Cited by 12
The Concept of Fitness and Drug Resistance in Leishmania
Ponte‐Sucre, A., Díaz, E., & Padrón-Nieves, M. (2012) · Springer eBooks · doi:10.1007/978-3-7091-1125-3_20 · Cited by 9
Self-citationMechanisms of Miltefosine Resistance in Leishmania
Gamarro, F., Sánchez‐Cañete, M. P., & Castanys, S. (2012) · Springer eBooks · doi:10.1007/978-3-7091-1125-3_17 · Cited by 7
Self-citation
Cited by
Ghasemian Yadegari, J., Khudair Khalaf, A., Ezzatkhah, F., Shakibaie, M., Mohammadi, H. R., & Mahmoudvand, H. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.114984 · Cited by 12
Metadata
- Authors
- Ponte-Sucre, A., Gamarro, F., Dujardin, J.-C., Barrett, M. P., López-Vélez, R., García-Hernández, R., Pountain, A. W., Mwenechanya, R., & Papadopoulou, B.
- Venue
- PLOS Neglected Tropical Diseases
- Publisher
- Public Library of Science (PLoS)
- Published
- 2017-12-14
- Volume
- 11
- Issue
- 12
- Pages
- e0006052
- ISSN
- 1935-2727 (ISSN-L)
- 1935-2735
- OpenAlex
- W2775643792
- Cited by
- 962
- References
- 80
- FWCI
- 61.04
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.